IL17A and lung carcinoma: The results from our study partially support the findings from the aforementioned study, as we also detected elevated levels of IL-17A in BALF of ICIaP that proved to be significantly higher compared to patients with lung cancer and patients with ILD other than ICIaP, but not in comparison to healthy subjects.